|
|
||||||||
1Critical Care and Respiratory Divisions, Department of Medicine, Royal Victoria Hospital, and Meakins-Christie Laboratories, McGill University Health Center, Montreal, H3A 1A1; 2Department of Pharmacology, Institut de Pharmacologie, Faculté de Médecine, Université de Sherbrooke; and 3Medical and Surgical Intensive Care Units, Université de Sherbrooke, Sherbrooke, J1H 5N4 Quebec, Canada
Submitted 31 July 2003 ; accepted in final form 11 November 2003
Apoptosis(programmed cell death) is induced in pulmonary cells and contributes to the pathogenesis of acute lung injury in septic humans. Previous studies have shown that nitric oxide (NO) is an important modulator of apoptosis; however, the functional role of NO derived from inducible NO synthase (iNOS) in sepsis-induced pulmonary apoptosis remains unknown. We measured pulmonary apoptosis in a rat model of Escherichia coli lipopolysaccharide (LPS)-induced sepsis in the absence and presence of the selective iNOS inhibitor 1400W. Four groups were studied 24 h after saline (control) or LPS injection in the absence and presence of 1400W pretreatment. Apoptosis was evaluated using DNA fragmentation, terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling staining, and caspase activation. LPS administration significantly augmented pulmonary cell apoptosis and caspase-3 activity in airway and alveolar epithelial cells. Pretreatment with 1400W significantly enhanced LPS-induced pulmonary apoptosis and increased caspase-3 and -7 activation. The antiapoptotic effect of iNOS was confirmed in iNOS-/- mice, which developed a greater degree of pulmonary apoptosis both under control conditions and in response to LPS compared with wild-type mice. By comparison, genetic deletion of the neuronal NOS had no effect on LPS-induced pulmonary apoptosis. We conclude that NO derived from iNOS plays an important protective role against sepsis-induced pulmonary apoptosis.
nitric oxide synthase; inducible; neuronal; lungs; caspase; acute lung injury
This article has been cited by other articles:
![]() |
P. S. Tang, M. Mura, R. Seth, and M. Liu Acute lung injury and cell death: how many ways can cells die? Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L632 - L641. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mori Regulation of Nitric Oxide Synthesis and Apoptosis by Arginase and Arginine Recycling J. Nutr., June 1, 2007; 137(6): 1616S - 1620S. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Carreras and J. J. Poderoso Mitochondrial nitric oxide in the signaling of cell integrated responses Am J Physiol Cell Physiol, May 1, 2007; 292(5): C1569 - C1580. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. S. Douglas, F. D. del Valle, R. A. Winn, and N. F. Voelkel beta-Catenin in the Fibroproliferative Response to Acute Lung Injury Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 274 - 285. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Mannick Immunoregulatory and antimicrobial effects of nitrogen oxides. Proceedings of the ATS, January 1, 2006; 3(2): 161 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Hauser, H. Bracht, M. Matejovic, P. Radermacher, and B. Venkatesh Nitric Oxide Synthase Inhibition in Sepsis? Lessons Learned from Large-Animal Studies Anesth. Analg., August 1, 2005; 101(2): 488 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Baron, I. M. Carvajal, X. Liu, R. O. Okabe, L. E. Fredenburgh, A. A. Macias, Y.-H. Chen, K. Ejima, M. D. Layne, and M. A. Perrella Reduction of Nitric Oxide Synthase 2 Expression by Distamycin A Improves Survival from Endotoxemia J. Immunol., September 15, 2004; 173(6): 4147 - 4153. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |